Preconditioning with Maillard reaction products improves antioxidant defence leading to increased stress tolerance in cardiac cells

Experimental Gerontology

Volumn 45, Issue 10, 2010, Pages 752-762

  Ruhs, Stefanie ^a   Nass, Norbert ^a   Bartling, Babett ^a   Brömme, Hans Jürgen ^a   Leuner, Beatrice ^a   Somoza, Veronika ^b   Friess, Ulrich ^c   Silber, Rolf Edgar ^a   Simm, Andreas ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b Research Platform Molecular Food Science   (Austria)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Advanced glycation endproducts; Cardiac fibroblasts; Cardiomyocytes; Oxidative stress; Preconditioning

Indexed keywords

ADVANCED GLYCATION END PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAD; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVATION; FIBROBLAST; GENE EXPRESSION; GLYCATION; HEART MUSCLE CELL; HEART PROTECTION; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

AGING; ANIMAL FEED; ANIMALS; ANTIOXIDANTS; BREAD; CELLS, CULTURED; FIBROBLASTS; GLYCOSYLATION END PRODUCTS, ADVANCED; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MAILLARD REACTION; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MYOCARDIUM; OXIDATIVE STRESS; RATS; RATS, WISTAR;

MUS; RATTUS; RODENTIA;

EID: 77957011135     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2010.08.001     Document Type: Article

References (68)

1. Andrassy M., Volz H.C., Igwe J.C., Funke B., Eichberger S.N., Kaya Z., Buss S., Autschbach F., Pleger S.T., Lukic I.K., Bea F., Hardt S.E., Humpert P.M., Bianchi M.E., Mairbäurl H., Nawroth P.P., Remppis A., Katus H.A., Bierhaus A. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 2008, 117(25):3216-3226.
2. Asif M., Egan J., Vasan S., Jyothirmayi G.N., Masurekar M.R., Lopez S., Williams C., Torres R.L., Wagle D., Ulrich P., Cerami A., Brines M., Regan T.J. An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness. Proc. Natl Acad. Sci. USA 2000, 97(6):2809-2813.
3. Bartling B., Friedrich I., Silber R.E., Simm A. Ischemic preconditioning is not cardioprotective in senescent human myocardium. Ann. Thorac. Surg. 2003, 76(1):105-111.
4. Bergmann R., Helling R., Heichert C., Scheunemann M., Mading P., Wittrisch H., Johannsen B., Henle T. Radio fluorination and positron emission tomography (PET) as a new approach to study the in vivo distribution and elimination of the advanced glycation endproducts N epsilon-carboxymethyllysine (CML) and N epsilon-carboxyethyllysine (CEL). Nahrung 2001, 45(3):182-188.
5. Bierhaus A., Humpert P.M., Morcos M., Wendt T., Chavakis T., Arnold B., Stern D.M., Nawroth P. Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 2005, 83(11):876-886.
6. Brown R.D., Ambler S.K., Mitchell M.D., Long C.S. The cardiac fibroblast therapeutic target in myocardial remodeling and failure. Annu. Rev. Pharmacol. Toxicol. 2005, 45:657-687.
7. Bruel A., Oxlund H. Changes in biomechanical properties, composition of collagen and elastin, and advanced glycation endproducts of the rat aorta in relation to age. Atherosclerosis 1996, 127(2):155-165.
8. Bucciarelli L.G., Ananthakrishnan R., Hwang Y.C., Kaneko M., Song F., Sell D.R., Strauch C., Monnier V.M., Yan S.F., Schmidt A.M., Ramasamy R. RAGE and modulation of ischemic injury in the diabetic myocardium. Diabetes 2008, 57(7):1941-1951.
9. Cai W., He J.C., Zhu L., Chen X., Wallenstein S., Striker G.E., Vlassara H. Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet association with increased AGER1 expression. Am. J. Pathol. 2007, 170(6):1893-1902.
10. Chuyen N.V. Toxicity of the AGEs generated from the Maillard reaction on the relationship of food-AGEs and biological-AGEs. Mol. Nutr. Food Res. 2006, 50(12):1140-1149.
11. 2-dependent arachidonic acid production in adult cardiac fibroblasts. FEBS Lett. 2005, 579(11):2533-2540.
12. Dyer D.G., Dunn J.A., Thorpe S.R., Lyons T.J., McCance D.R., Baynes J.W. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. Ann. NY Acad. Sci. 1992, 663:421-422.
13. Dyer B.W., Ferrer F.A., Klinedinst D.K., Rodriguez R. A noncommercial dual luciferase enzyme assay system for reporter gene analysis. Anal. Biochem. 2000, 282(1):158-161.
14. Espira L., Czubryt M.P. Emerging concepts in cardiac matrix biology. Can. J. Physiol. Pharmacol. 2009, 87(12):996-1008.
15. Feng W., Benz F.W., Cai J., Pierce W.M., Kang Y.J. Metallothionein disulfides are present in metallothionein-overexpressing transgenic mouse heart and increase under conditions of oxidative stress. J. Biol. Chem. 2006, 281(2):681-687.
16. Fu S., Fu M.X., Baynes J.W., Thorpe S.R., Dean R.T. Presence of dopa and amino acid hydroperoxides in proteins modified with advanced glycation end products (AGEs) amino acid oxidation products as a possible source of oxidative stress induced by AGE proteins. Biochem. J. 1998, 330(Pt 1):233-239.
17. Ghosh M., Talukdar D., Ghosh S., Bhattacharyya N., Ray M., Ray S. In vivo assessment of toxicity and pharmacokinetics of methylglyoxal. Augmentation of the curative effect of methylglyoxal on cancer-bearing mice by ascorbic acid and creatine. Toxicol. Appl. Pharmacol. 2006, 212(1):45-58.
18. Goya L., Delgado-Andrade C., Rufian-Henares J.A., Bravo L., Morales F.J. Effect of coffee melanoidin on human hepatoma HepG2 cells. Protection against oxidative stress induced by tert-butylhydroperoxide. Mol. Nutr. Food. Res. 2007, 51(5):536-545.
19. Hausenloy D.J., Yellon D.M. Preconditioning and postconditioning underlying mechanisms and clinical application. Atherosclerosis 2009, 204(2):334-341.
20. Juhaszova M., Rabuel C., Zorov D.B., Lakatta E.G., Sollott S.J. Protection in the aged heart: preventing the heart-break of old age?. Cardiovasc. Res. 2005, 66(2):233-244.
21. Kang Y.J. The antioxidant function of metallothionein in the heart. Proc. Soc. Exp. Biol. Med. 1999, 222(3):263-273.
22. Koschinsky T., He C.J., Mitsuhashi T., Bucala R., Liu C., Buenting C., Heitmann K., Vlassara H. Orally absorbed reactive glycation products (glycotoxins) an environmental risk factor in diabetic nephropathy. Proc. Natl Acad. Sci. USA 1997, 94(12):6474-6479.
23. Lee H.J., Howell S.K., Sanford R.J., Beisswenger P.J. Methylglyoxal can modify GAPDH activity and structure. Ann. NY Acad. Sci. 2005, 1043:135-145.
24. Lindenmeier M., Hofmann T. Influence of baking conditions and precursor supplementation on the amounts of the antioxidant Pronyl-l-lysine in bakery products J. Agric. Food Chem. 2004, 52:350-354.
25. Lindenmeier M., Faist V., Hofmann T. Structural and functional characterization of pronyl-lysine, a novel protein modification in bread crust melanoidins showing in vitro antioxidative and phase I/II enzyme modulating activity. J. Agric. Food Chem. 2002, 50(24):6997-7006.
26. Martindale J.L., Holbrook N.J. Cellular response to oxidative stress signaling for suicide and survival. J. Cell. Physiol. 2002, 192(1):1-15.
27. Meerwaldt R., Lutgers H.L., Links T.P., Graaff R., Baynes J.W., Gans R.O., Smit A.J. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diab. Care 2007, 30(1):107-112.
28. Murphy E., Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol. Rev. 2008, 88(2):581-609.
29. Nagaraj R.H., Oya-Ito T., Padayatti P.S., Kumar R., Mehta S., West K., Levison B., Sun J., Crabb J.W., Padival A.K. Enhancement of chaperone function of alpha-crystallin by methylglyoxal modification. Biochemistry 2003, 42(36):10746-10755.
30. Nass N., Bartling B., Navarrete Santos A., Scheubel R.J., Börgermann J., Silber R.E., Simm A. Advanced glycation end products, diabetes and ageing. Z. Gerontol. Geriatr. 2007, 40(5):349-356.
31. (0) cells without a functional respiratory chain. Biol. Chem. 2009, 390(9):915-919.
32. Nass N., Vogel K., Hofmann B., Presek P., Silber R.E., Simm A. Glycation of PDGF results in decreased biological activity. Int. J. Biochem. Cell Biol. 2010, 42(5):749-754.
33. Patel B.N., Dunn R.J., Jeong S.Y., Zhu Q., Julien J.P., David S. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J. Neurosci. 2002, 22(15):6578-9586.
34. Pell T.J., Yellon D.M., Goodwin R.W., Baxter G.F. Myocardial ischemic tolerance following heat stress is abolished by ATP-sensitive potassium channel blockade. Cardiovasc. Drugs Ther. 1997, 11(5):679-686.
35. Piper H.M., Probst I., Schwartz P., Hutter F.J., Spieckermann P.G. Culturing of calcium stable adult cardiac myocytes. J. Mol. Cell. Cardiol. 1982, 14(7):397-412.
36. Pitari G., Malergue F., Martin F., Philippe J.M., Massucci M.T., Chabret C., Maras B., Dupre S., Naquet P., Galland F. Pantetheinase activity of membrane-bound Vanin-1 lack of free cysteamine in tissues of Vanin-1 deficient mice. FEBS Lett. 2000, 483(2-3):149-154.
37. Rong L.L., Gooch C., Szabolcs M., Herold K.C., Lalla E., Hays A.P., Yan S.F., Yan S.S., Schmidt A.M. RAGE a journey from the complications of diabetes to disorders of the nervous system - striking a fine balance between injury and repair. Restor. Neurol. Neurosci. 2005, 23(5-6):355-365.
38. Ruhs S., Nass N., Somoza V., Friess U., Schinzel R., Silber R.E., Simm A. Maillard reaction products enriched food extract reduce the expression of myofibroblast phenotype markers. Mol. Nutr. Food Res. 2007, 51(4):488-495.
39. Sato Y., Kondo T., Ohshima T. Estimation of age of human cadavers by immunohistochemical assessment of advanced glycation end products in the hippocampus. Histopathology 2001, 38(3):217-220.
40. Sebekova K., Somoza V. Dietary advanced glycation endproducts (AGEs) and their health effects-PRO. Mol. Nutr. Food Res. 2007, 51(9):1079-1084.
41. Šebeková K., Hofmann T., Boor P., Šebeková K., Uličná O., Erbersdobler H.F., Baynes J.W., Thorpe S.R., Heidland A., Somoza V. Renal effects of oral Maillard reaction products load in form of bread crusts in healthy and subtotally nephrectomized rats. Ann. N.Y. Acad. Sci. 2005, 1043:482-491.
42. Sell D.R., Kleinman N.R., Monnier V.M. Longitudinal determination of skin collagen glycation and glycoxidation rates predicts early death in C57BL/6NNIA mice. FASEB J. 2000, 14(1):145-156.
43. Shang L., Ananthakrishnan R., Li Q., Quadri N., Abdillahi M., Zhu Z., Qu W., Rosario R., Touré F., Yan S.F., Schmidt A.M., Ramasamy R. RAGE modulates hypoxia/reoxygenation injury in adult murine cardiomyocytes via JNK and GSK-3beta signaling pathways. PLoS ONE 2010, 5(4):e10092.
44. Simm A., Munch G., Seif F., Schenk O., Heidland A., Richter H., Vamvakas S., Schinzel R. Advanced glycation endproducts stimulate the MAP-kinase pathway in tubulus cell line LLC-PK1. FEBS Lett. 1997, 410(2-3):481-484.
45. Simm A., Wagner J., Gursinsky T., Nass N., Friedrich I., Schinzel R., Czeslik E., Silber R.E., Scheubel R.J. Advanced glycation endproducts a biomarker for age as an outcome predictor after cardiac surgery?. Exp Gerontol. 2007, 42(7):668-675.
46. Somoza V. Five years of research on health risks and benefits of Maillard reaction products an update. Mol. Nutr. Food Res. 2005, 49(7):663-672.
47. Somoza V. Health implications of thermally processed foods -COST Action 927. Mol. Nutr. Food Res. 2006, 50(9):787-788.
48. Somoza V. Physiological effects of thermally treated foods. Mol. Nutr. Food Res. 2008, 52(3):305-306.
49. Somoza V., Lindenmeier M., Hofmann T., Frank O., Erbersdobler H.F., Baynes J.W., Thorpe S.R., Heidland A., Zill H., Bek S., Huber J., Weigle T., Scheidler S., Busch A.E., Sebekova K. Dietary bread crust advanced glycation end products bind to the receptor for AGEs in HEK-293 kidney cells but are rapidly excreted after oral administration to healthy and subtotally nephrectomized rats. Ann. N.Y. Acad. Sci. 2005, 1043:492-500.
50. Somoza V., Wenzel E., Lindenmeier M., Grothe D., Erbersdobler H.F., Hofmann T. Influence of feeding malt, bread crust, and a pronylated protein on the activity of chemopreventive enzymes and antioxidative defense parameters in vivo. J. Agric. Food Chem. 2005, 53(21):8176-8182.
51. Somoza V., Wenzel E., Weiss C., Clawin-Radecker I., Grubel N., Erbersdobler H.F. Dose-dependent utilisation of casein-linked lysinoalanine, N(epsilon)-fructoselysine and N(epsilon)-carboxymethyllysine in rats. Mol. Nutr. Food Res. 2006, 50(9):833-841.
52. Stirban A., Negrean M., Stratmann B., Gawlowski T., Horstmann T., Gotting C., Kleesiek K., Mueller-Roesel M., Koschinsky T., Uribarri J., Vlassara H., Tschoepe D. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diab. Care 2006, 29(9):2064-2071.
53. Takeuchi M., Yamagishi S. TAGE (toxic AGEs) hypothesis in various chronic diseases. Med. Hypotheses 2004, 63(3):449-452.
54. Tikellis C., Thomas M.C., Harcourt B.E., Coughlan M.T., Pete J., Bialkowski K., Tan A., Bierhaus A., Cooper M.E., Forbes J.M. Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E323-E330.
55. Tomasini R., Samir A.A., Vaccaro M.I., Pebusque M.J., Dagorn J.C., Iovanna J.L., Dusetti N.J. Molecular and functional characterization of the stress-induced protein (SIP) gene and its two transcripts generated by alternative splicing. SIP induced by stress and promotes cell death. J. Biol. Chem. 2001, 276(47):44185-44192.
56. 53-dependent expression of the stress-induced protein (SIP). Eur. J. Cell Biol. 2002, 81(5):294-301.
57. Ulrich P., Cerami A. Protein glycation, diabetes, and aging. Recent Prog. Horm. Res. 2001, 56:1-21.
58. Valen G. Cellular signalling mechanisms in adaptation to ischemia-induced myocardial damage. Ann. Med. 2003, 35(5):300-307.
59. Vellaichamy E., Khurana M.L., Fink J., Pandey K.N. Involvement of the NF-kappa B/matrix metalloproteinase pathway in cardiac fibrosis of mice lacking guanylyl cyclase/natriuretic peptide receptor A. J. Biol. Chem. 2005, 280(19):19230-19242.
60. Verzijl N., DeGroot J., Oldehinkel E., Bank R.A., Thorpe S.R., Baynes J.W., Bayliss M.T., Bijlsma J.W., Lafeber F.P., Tekoppele J.M. Age-related accumulation of Maillard reaction products in human articular cartilage collagen. Biochem. J. 2000, 350(Pt 2):381-387.
61. Vlassara H. The AGE-receptor in the pathogenesis of diabetic complications. Diabetes Metab. Res. Rev. 2001, 17(6):436-443.
62. Vlassara H., Cai W., Crandall J., Goldberg T., Oberstein R., Dardaine V., Peppa M., Rayfield E.J. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc. Natl Acad. Sci. USA 2002, 99(24):15596-15601.
63. Webster J., Wilke M., Stahl P., Kientsch-Engel R., Munch G. Maillard reaction products in food as pro-inflammatory and pro-arteriosclerotic factors of degenerative diseases. Z. Gerontol. Geriatr. 2005, 38(5):347-353.
64. Weiner L.M., Hu H., Swartz H.M. EPR method for the measurement of cellular sulfhydryl groups. FEBS Lett. 1991, 290(1-2):243-246.
65. Winyard P.G., Moody C.J., Jacob C. Oxidative activation of antioxidant defence. Trends Biochem. Sci. 2005, 30(8):453-461.
66. Wolffenbuttel B.H., Boulanger C.M., Crijns F.R., Huijberts M.S., Poitevin P., Swennen G.N., Vasan S., Egan J.J., Ulrich P., Cerami A., Levy B.I. Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc. Natl Acad. Sci. USA 1998, 95(8):4630-4634.
67. Zill H., Gunther R., Erbersdobler H.F., Folsch U.R., Faist V. RAGE expression and AGE-induced MAP kinase activation in Caco-2 cells. Biochem. Biophys. Res. Commun. 2001, 288(5):1108-1111.
68. Zill H., Bek S., Hofmann T., Huber J., Frank O., Lindenmeier M., Weigle B., Erbersdobler H.F., Scheidler S., Busch A.E., Faist V. RAGE-mediated MAPK activation by food-derived AGE and non-AGE products. Biochem. Biophys. Res. Commun. 2003, 300(2):311-315.